Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aline G Costa

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Current Osteoporosis Reports|October 18, 2015
How Long to Treat with DenosumabAline G Costa, John P Bilezikian
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|February 5, 2013
Bone turnover markers in primary hyperparathyroidismAline G Costa, John P Bilezikian
Current Osteoporosis Reports|January 12, 2012
Sclerostin: therapeutic horizons based upon its actionsAline G Costa, John P Bilezikian
Bone|October 16, 2016
Sclerostin measurement in human disease: Validity and current limitationsAline G Costa, Serge Cremers, John P Bilezikian
Expert Opinion on Biological Therapy|March 27, 2014
Update on romosozumab : a humanized monoclonal antibody to sclerostinAline G Costa, John P Bilezikian, E Michael Lewiecki
Current Opinion in Nephrology and Hypertension|June 8, 2015
The potential use of antisclerostin therapy in chronic kidney disease-mineral and bone disorderAline G Costa, John P Bilezikian, E Michael Lewiecki
Clinical Obstetrics and Gynecology|September 17, 2013
Osteoporosis: what's new and on the horizonBarbara C Silva, Aline G Costa, Natalie E Cusano, et al.
Journal of Osteoporosis|December 2, 2011
Therapy of osteoporosis in men with teriparatideNatalie E Cusano, Aline G Costa, Barbara C Silva, et al.
Nature Reviews. Rheumatology|June 15, 2011
Cathepsin K: its skeletal actions and role as a therapeutic target in osteoporosisAline G Costa, Natalie E Cusano, Barbara C Silva, et al.
The Journal of Clinical Endocrinology and Metabolism|August 28, 2014
Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International WorkshopRichard Eastell, Maria Luisa Brandi, Aline G Costa, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Current Osteoporosis Reports|October 18, 2015
How Long to Treat with DenosumabAline G Costa, John P Bilezikian
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|February 5, 2013
Bone turnover markers in primary hyperparathyroidismAline G Costa, John P Bilezikian
Current Osteoporosis Reports|January 12, 2012
Sclerostin: therapeutic horizons based upon its actionsAline G Costa, John P Bilezikian
Bone|October 16, 2016
Sclerostin measurement in human disease: Validity and current limitationsAline G Costa, Serge Cremers, John P Bilezikian
Expert Opinion on Biological Therapy|March 27, 2014
Update on romosozumab : a humanized monoclonal antibody to sclerostinAline G Costa, John P Bilezikian, E Michael Lewiecki
Current Opinion in Nephrology and Hypertension|June 8, 2015
The potential use of antisclerostin therapy in chronic kidney disease-mineral and bone disorderAline G Costa, John P Bilezikian, E Michael Lewiecki
Clinical Obstetrics and Gynecology|September 17, 2013
Osteoporosis: what's new and on the horizonBarbara C Silva, Aline G Costa, Natalie E Cusano, et al.
Journal of Osteoporosis|December 2, 2011
Therapy of osteoporosis in men with teriparatideNatalie E Cusano, Aline G Costa, Barbara C Silva, et al.
Nature Reviews. Rheumatology|June 15, 2011
Cathepsin K: its skeletal actions and role as a therapeutic target in osteoporosisAline G Costa, Natalie E Cusano, Barbara C Silva, et al.
The Journal of Clinical Endocrinology and Metabolism|August 28, 2014
Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International WorkshopRichard Eastell, Maria Luisa Brandi, Aline G Costa, et al.
Pageof 2